Tectonic Therapeutic, Inc.’s TECX share price has dipped by 6.52%, which has investors questioning if this is right time to buy.

A gastrointestinal cause of anaemia was suspected and oesophagogastroduodenoscopy (OGD) was performed, revealing multiple reddish lesions in the gastric fundus, body and antrum as well as in the ...

More information: Yaël P. Mossé et al, Anaplastic Lymphoma Kinase Inhibition Therapy for Hereditary Neuroblastoma, JCO Precision Oncology (2025). DOI: 10.1200/PO-24-00886 Journal information ...

Completed Approximately $185.0 Million Private Placement: In February 2025, Tectonic entered into a securities purchase agreement for a private investment in public equity financing ("PIPE”) that ...

Please try again later. ERBIL, Kurdistan Region - Seven people have died from Crimean-Congo Hemorrhagic Fever (CCHF) in Iraq and 53 others have been confirmed to be infected, a senior official ...

Mathematicians love the certainty of proofs. This is how they verify that their intuition matches observable truth. This logical love of proofs is uniquely suited to opening up the black box of ...

He was confused when he started feeling fatigued and later experienced severe bleeding from his gums. It turned out that Gaz was actually experiencing symptoms of leukaemia, a cancer of the white ...

The US Food and Drug Administation (FDA) has approved BlackfinBio Limited’s Phase 1/2 clinical trial for its novel adeno-associated virus (AAV) gene therapy targeting Hereditary Spastic Paraplegia ...

The company is on track to complete enrollment in the global Phase 3 HAELO study for hereditary angioedema (HAE) by the third quarter of 2025 and has dosed the first patient in the Phase 3 ...

Grifols has filed for US approval of a new drug for rare bleeding disorder acquired fibrinogen deficiency (AFD), which promises to provide a more reliable and easier treatment for patients.